Fetal Embolization for Vein of Galen Malformation

DO
Overseen ByDarren Orbach, MD PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Darren Orbach
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a treatment for fetuses with vein of Galen malformation, a rare abnormality in the brain's blood vessels. The trial aims to determine if fetal embolization is a safe and effective treatment for this condition before birth. The procedure uses detachable coils (Target XL and XXL Detachable Coils) to block the abnormal blood vessels. Pregnant women carrying a fetus diagnosed with this malformation, as confirmed by specific imaging criteria, may be suitable candidates. Participants will receive regular check-ups during pregnancy and follow-ups for two years after delivery to monitor the baby’s neurological development. As an unphased trial, this study offers a unique opportunity to contribute to pioneering research that could improve outcomes for future patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are on anticoagulation medication, you may not be eligible to participate.

What prior data suggests that fetal embolization is safe for treating Vein of Galen Malformation?

Research shows that using Target XL and XXL Detachable Coils to treat Vein of Galen Malformation (VOGM) in unborn babies is a new method, and researchers are still collecting safety information. Previous studies have not specifically examined this treatment in fetuses. The goal is to determine if the treatment is safe and effective before birth. One study discussed the safety of this procedure during pregnancy, but clear data on side effects or risks is not yet available. Currently, the treatment is intended to be safe, but more evidence is needed. Participants will have regular check-ups to monitor any effects and ensure safety.12345

Why are researchers excited about this trial?

Unlike traditional treatments for vein of Galen malformation, which typically involve postnatal surgical interventions, the fetal embolization approach using Target XL and XXL Detachable Coils offers a groundbreaking prenatal solution. This technique is unique because it allows for intervention while the baby is still in the womb, potentially reducing the risk of heart failure and brain damage associated with this condition. Researchers are excited about this method as it targets the malformation early, which could lead to better outcomes by preventing severe symptoms before birth.

What evidence suggests that fetal embolization is effective for Vein of Galen Malformation?

Research has shown that using Target XL and XXL Detachable Coils might help treat Vein of Galen Malformation (VOGM). This trial involves a single-arm study where fetal subjects undergo a one-time intervention of fetal embolization using these coils. The method places tiny coils in the abnormal blood vessels to block them. Although direct data on using this procedure in unborn babies is limited, similar methods in older patients have shown promise in reducing blood flow problems caused by VOGM. The aim of using these coils is to prevent complications before birth, potentially leading to better outcomes. Early findings suggest this treatment might help manage the condition, but more research is needed to confirm its effectiveness in unborn babies.12345

Who Is on the Research Team?

DO

Darren Orbach, MD PhD

Principal Investigator

Boston Children's Hospital

Are You a Good Fit for This Trial?

This trial is for pregnant women with a fetus diagnosed with Vein of Galen Malformation (VOGM), where the affected sinus measures at least 8 mm. The mother must be over 18, able to travel for study visits, and have a well-preserved fetal brain structure. Exclusions include preterm labor risks, maternal coagulopathy or diseases requiring anticoagulation, prior conditions preventing epidural anesthesia, multiple pregnancies, placenta issues, other conflicting studies participation, metal hypersensitivity and severe obesity.

Inclusion Criteria

I am pregnant and my fetus has a specific brain vessel malformation diagnosed by MRI.
I am a candidate for continuous lower back pain relief through an epidural.
My brain tissue is healthy.
See 3 more

Exclusion Criteria

Unborn babies with a specific type of brain blood vessel abnormality that measures less than 8 mm on a special type of MRI test will not be included in the study.
Unborn babies with serious birth defects.
You are showing signs of early labor, water breaking, or separation of the placenta.
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Fetal Intervention

A one-time fetal embolization procedure is performed using maternal transuterine, fetal transcranial torcular puncture and median prosencephalic vein embolization.

1 day
1 visit (in-person)

Prenatal Follow-up

Data is collected every 4 weeks post-procedure until delivery to monitor safety and efficacy.

Until delivery
Every 4 weeks (in-person)

Postnatal Follow-up

Neurological assessments are performed every 6 months for 2 years after delivery to monitor long-term outcomes.

2 years
Every 6 months (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Target XL and XXL Detachable Coils
Trial Overview The trial tests fetal embolization using Target XL and XXL Detachable Coils on fetuses with VOGM to evaluate safety and effectiveness. It's a single-arm study comparing results against historical data. Participants undergo one-time embolization followed by regular check-ups until delivery and neurological assessments every six months post-delivery for two years.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Fetal embolization of vein of Galen malformationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Darren Orbach

Lead Sponsor

Trials
1
Recruited
30+

Citations

NCT04434729 | Fetal Treatment of Galenic MalformationsDetachable platinum coils (Target XL and XXL Detachable Coil, Stryker Neurovascular) will be used to pack the prosencephalic varix. What is the study measuring?
NCT04434729This is a prospective, single-arm non-randomized interventional study of fetuses to assess the safety and efficacy of fetal embolization of Vein of Galen ...
Fetal Embolization for Vein of Galen MalformationTrial Overview The trial tests fetal embolization using Target XL and XXL Detachable Coils on fetuses with VOGM to evaluate safety and effectiveness. It's a ...
Fetal Treatment of Galenic MalformationsDetachable platinum coils (Target XL and XXL Detachable Coil, Stryker Neurovascular) will be used to pack the prosencephalic varix. This ...
Percutaneous transuterine fetal cerebral embolisation to treat ...This study investigates the safety and potential benefit of treating a VOGM in utero, which has not been previously studied.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security